Skip to main content
. 2017 Jun 12;7:248. doi: 10.3389/fcimb.2017.00248

Figure 1.

Figure 1

Proposed mechanism for immune activation of T cells by glycoconjugate vaccines. The carbohydrate-protein conjugate is recognized by carbohydrate-specific B cells. The protein component of the conjugate is subsequently endocytosed, processed and presented on MHCII molecules of the carbohydrate specific B cell in order to activate a T cell for co-stimulation.